Skip to main content

Turns Out Your Genes Might Decide How Well Weight-Loss Drugs Work

Unlock greater weight loss! New research shows people with specific gene variations linked to appetite and digestion lose more when taking obesity drugs.

Sophia Brennan
Sophia Brennan
·3 min read·2 views
Share

You know those incredibly popular weight-loss drugs, the ones like Wegovy and Mounjaro, that have basically taken over the internet and every dinner party conversation? Well, new research suggests that whether they turn you into a lean, mean, fat-shedding machine or just make you feel a bit queasy might actually be written in your DNA.

These medications are designed to mimic a natural gut hormone, essentially tricking your body into feeling full and curbing that relentless hunger. Pretty clever stuff, right? But it turns out, not everyone gets the same mileage.

Your DNA on Drugs

A recent study, published in Nature, peered into the genetic makeup of 15,000 people taking these drugs. On average, participants shed about 11.7% of their body weight over eight months. Which, let's be honest, is a pretty satisfying number. But here's the kicker: some people dropped a whopping 30%, while others barely moved the needle. And some just got a lot of nausea.

Wait—What is Brightcast?

We're a new kind of news feed.

Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.

Start Your News Detox

Researchers, who had access to 23andMe genetic data (because apparently that's where we are now), started connecting the dots. They found specific genetic variations linked to both greater weight loss and those less-than-pleasant side effects like nausea and vomiting.

Professor Ruth Loos from the University of Copenhagen pointed to one particular variant that added an extra 1.6 pounds of weight loss, on average. If you happen to carry two copies of this variant? Double the fun, double the weight loss. Which, if you think about it, is both impressive and slightly terrifying for anyone without it.

Interestingly, this particular variant is more common in people of European ancestry, with 64% carrying one copy and 16% carrying two. For African Americans, that number drops to 7%. Another variant popped up, potentially explaining why up to 1% of users on tirzepatide (Mounjaro) experience severe vomiting – nearly 15 times worse than the typical user. Because, you know, regular vomiting just wasn't bad enough.

Loos described the genetic effect as 'modest but "not trivial,"' which is basically science-speak for 'it's not everything, but it's definitely something worth paying attention to.'

More Than Just Genes

Before you start blaming your ancestors for your lack of drug-induced weight loss, Dr. Marie Spreckley from the University of Cambridge reminds us that genetics are just one piece of a very complex pie. Behavioral factors, like your daily exercise routine and eating habits, along with clinical support and other health issues, still play a starring role.

Other factors also weigh in:

  • Sex: Women are twice as likely as men to hit that 15% weight loss mark on Mounjaro.
  • Age and Ancestry: Being younger, white, or Asian also correlates with more weight loss. The 'why' is still a bit of a mystery, which is always fun.
  • The Drug Itself: The type of medication, its dosage, and how long you take it are also crucial.

The dream, of course, is 'precision medicine' – using your genetic blueprint and all these other factors to pick the perfect weight-loss drug for you. But Professor Naveed Sattar, a metabolic health expert from the University of Glasgow, offers a dose of reality, noting that we're still a long way from this changing clinical practice. More robust data is needed to truly understand the full picture of benefits and harms. So, for now, your doctor probably won't be swabbing your cheek before writing a prescription. But who knows what the future holds?

Brightcast Impact Score (BIS)

This article highlights a scientific discovery that sheds new light on the efficacy of weight-loss drugs, identifying genetic factors that influence individual responses. This research could lead to more personalized and effective treatment plans for obesity, offering hope for better health outcomes for many. The findings are published in a reputable scientific journal, indicating strong evidence.

Hope27/40

Emotional uplift and inspirational potential

Reach22/30

Audience impact and shareability

Verification25/30

Source credibility and content accuracy

Significant
74/100

Major proven impact

Start a ripple of hope

Share it and watch how far your hope travels · View analytics →

You
friendstheir friendsand beyond...

Wall of Hope

0/20

Be the first to share how this story made you feel

How does this make you feel?

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Connected Progress

Originally reported by BBC Health · Verified by Brightcast

More stories that restore faith in humanity